Algen Biotechnologies
Using CRISPR to find treatments for cancer and inflammation
AI & Machine Learning
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Open Roles
No open roles right now.
Verified Team
No verified team members yet.